Identity graph
Auravax Therapeutics headquarters, locations and relationships
- Legal name
- Auravax Therapeutics, Inc.
- Industry
- Biotechnology
- Founded
- 2020
- Website
- auravax.com
Auravax Therapeutics office locations
No office locations recorded yet.
- Parent company
- No parent company recorded in GraphIQ.ai.
Verified from public filings, company websites and news · Methodology
Open in GraphIQ.aiMore Auravax Therapeutics data in GraphIQ.ai
This page shows the public record. Sign in with a work email to open the rest of the entity.
-
Technographics (available after sign-in)
Software, cloud and infrastructure in use.
-
Firmographics (available after sign-in)
Revenue, headcount, growth and industry codes.
-
Capabilities (available after sign-in)
Products, services and certifications.
-
News (available after sign-in)
Recent coverage and signals, resolved to the entity.
-
And more (available after sign-in)
Subsidiaries, people and lookalike companies.
Who uses the Auravax Therapeutics entity
-
Revenue and GTM teams
Territories, enrichment and account expansion on one resolved account.
RevOps Sales & marketing -
Industry and supply chain
Suppliers, sites and partners mapped to the right legal entity.
Industry -
Private equity and investors
Corporate family, comparable companies and deal sourcing.
Private equity -
Government and public sector
Supplier vetting, ownership and jurisdiction checks against one verified entity.
Government -
Developers and AI agents
The entity and its relationships through the REST API and MCP server.
Developers
About Auravax Therapeutics
Auravax Therapeutics: Biotechnology company offering COVID-19 vaccines. Founded in 2020, the company employs approximately 3 people worldwide.
What does Auravax Therapeutics do?
AuraVax Therapeutics, Inc. is a privately held biopharmaceutical company developing NanoSTING for the treatment and prevention of upper respiratory disease due to all major viral pathogens. This platform activates the STING pathway to trigger an effective innate immune response upon intranasal delivery. We are developing NanoSTING for global access to address the disease burden of current respiratory viruses and future emerging pathogens.
One entity, every stage
Put Auravax Therapeutics to work across your revenue bowtie
- Target Define the market Build the account list from companies shaped like your best customers, Auravax Therapeutics included. Fingerprint search
- Cover Plan territories Auravax Therapeutics resolves to one account, so it lands in one territory, once. Territory planning
- Engage Act on timing Leadership changes, funding and M&A arrive linked to the account, not a loose headline. Signal monitoring
- Convert Close on a resolved record Inbound and closed-won attach to one CRM record, with no duplicates to merge. CRM enrichment
- Retain Ground every answer Customer teams and AI agents answer from the same entity, with a source and a date. AI agent data layer
- Expand Find the next buyer inside Follow subsidiaries and divisions to the next team that can buy. Account expansion
About the source
What is GraphIQ.ai?
A B2B identity graph. It resolves each organization into one verified entity and maps its parent and subsidiaries, employees, competitors and news signals. Revenue teams use it in the product; AI agents query it through the REST API and MCP server.
POST/api/v2/organizations/search
Auravax Therapeutics: frequently asked questions
When was Auravax Therapeutics founded?
2020.
How many employees does Auravax Therapeutics have?
About 3, as of October 2026 (GraphIQ.ai estimate).
Questions about GraphIQ.ai
Is GraphIQ.ai a list of companies like a spreadsheet?
No. Each organization resolves to one verified entity linked to its parent, subsidiaries, people and signals, so Auravax Therapeutics here is the same Auravax Therapeutics in your CRM, territory plan and agent answers.
Where does this Auravax Therapeutics data come from?
Public filings, company websites and news, resolved to one entity and continuously updated.